« « Talk on diabetes management – Moorpark Acorn
| Men With Diabetes Don't Know the Facts – WebMD » »
Biodel shares fall on diabetes drug concern – Forbes
Friday, September 12th, 2008 Subscribe To Our Feed
|
Biodel shares fall on diabetes drug concern
Forbes,?NY?- 8 hours ago The company said Viaject met its goals in a pair of current trials, but it discounted some of the results from the type 1 diabetes trial. … |
Source:Biodel shares fall on diabetes drug concern – Forbes
No Tags
Posted in insulin | | Top Of Page
Site Search Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Possible Related Posts
UPDATE 3-Biodel shares dive as diabetes study disappoints – ReutersAmylin shares recover on diabetes drug data – ForbesAmylin shares plunge on FDA study data rejection – Forbes
